Trichoderma species fungemia after high‐dose chemotherapy and autologous stem cell transplantation: a case report

We present a case of Trichoderma fungemia with pulmonary involvement in a multiple myeloma patient, who was severely immunocompromised and heavily treated with high‐dose melphalan, and underwent autologous hematopoietic cell transplantation. This is the first report, to our knowledge, of proven Trichoderma fungemia, defined by published criteria, successfully treated with voriconazole.

[1]  P. G. Choe,et al.  The effect of therapeutic drug monitoring on safety and efficacy of voriconazole in invasive fungal infections: a randomized controlled trial. , 2012, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2]  A. Thiébaut,et al.  European guidelines for antifungal management in leukemia and hematopoietic stem cell transplant recipients: summary of the ECIL 3—2009 Update , 2011, Bone Marrow Transplantation.

[3]  E. Anaissie,et al.  Epidemiology and outcome of invasive fungal infection in adult hematopoietic stem cell transplant recipients: analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance registry. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[4]  S. Gallien,et al.  Trichoderma fungaemia in a neutropenic patient with pulmonary cancer and human immunodeficiency virus infection. , 2008, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[5]  J. Perfect,et al.  Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  A. Baruchel,et al.  Invasive pulmonary infection due to Trichoderma longibrachiatum mimicking invasive Aspergillosis in a neutropenic patient successfully treated with voriconazole combined with caspofungin. , 2008, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[7]  C. Burgaleta,et al.  Nonfatal pulmonary Trichoderma viride infection in an adult patient with acute myeloid leukemia: report of one case and review of the literature. , 2005, Diagnostic microbiology and infectious disease.

[8]  C. Utaş,et al.  Fatal Peritonitis due to Trichoderma sp. in a patient undergoing continuous ambulatory peritoneal dialysis , 2003, Mycoses.

[9]  L. Lachaud,et al.  Invasive infections due to Trichoderma species: report of 2 cases, findings of in vitro susceptibility testing, and review of the literature. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  H. Asaoku,et al.  Fatal necrotizing stomatitis due to Trichoderma longibrachiatum in a neutropenic patient with malignant lymphoma: a case report. , 2002, International journal of oral and maxillofacial surgery.

[11]  A. Torino,et al.  Unsuspected embolic fungal endocarditis of an aortic conduit diagnosed by transesophageal echocardiography. , 2000, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.

[12]  S. Sanche,et al.  Rapid Identification of Fungi by Using the ITS2 Genetic Region and an Automated Fluorescent Capillary Electrophoresis System , 2000, Journal of Clinical Microbiology.

[13]  M. Cormican,et al.  Fatal Disseminated Trichoderma longibrachiatum Infection in an Adult Bone Marrow Transplant Patient: Species Identification and Review of the Literature , 1999, Journal of Clinical Microbiology.

[14]  E. Guého,et al.  Molecular reidentification of human pathogenic Trichoderma isolates as Trichoderma longibrachiatum and Trichoderma citrinoviride. , 1999, Medical mycology.

[15]  S. Todo,et al.  Acute invasive sinusitis due to Trichoderma longibrachiatum in a liver and small bowel transplant recipient. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[16]  S. Rossmann,et al.  Trichoderma longibrachiatum infection in a pediatric patient with aplastic anemia , 1997, Journal of clinical microbiology.

[17]  M. Campos-Herrero,et al.  Trichodermia koningii peritonitis in a patient undergoing peritoneal dialysis , 1996 .

[18]  A. Gacouin,et al.  Successful treatment of a brain abscess due toTrichoderma longibrachiatum after surgical resection , 1995, European Journal of Clinical Microbiology and Infectious Diseases.

[19]  R A Kyle,et al.  Criteria for diagnosis, staging, risk stratification and response assessment of multiple myeloma , 2009, Leukemia.

[20]  T J Walsh,et al.  Infections due to emerging and uncommon medically important fungal pathogens. , 2004, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[21]  D. Denning,et al.  Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[22]  E. Guého,et al.  Molecular reidentification of human pathogenicTrichodermaisolates asTrichoderma longibrachiatumandTrichoderma citrinoviride , 1999 .

[23]  A. Michault,et al.  Trichoderma harzianum peritonitis in peritoneal dialysis. , 1996, Nephron.